Expression, production, and renaturation of a functional single-chain variable antibody fragment (scFv) against human ICAM-1

被引:13
作者
Sun, H. [1 ,2 ]
Wu, G. M. [1 ]
Chen, Y. Y. [3 ,4 ,5 ]
Tian, Y. [1 ]
Yue, Y. H. [1 ]
Zhang, G. L. [1 ]
机构
[1] Acad Mil Med Sci, Inst Mil Vet, Changchun 130122, Peoples R China
[2] Heilongjiang Vocat Coll Biol Sci & Technol, Dept Biol Pharm, Harbin, Peoples R China
[3] Peking Union Med Coll, Inst Med Biotechnol, Beijing 100021, Peoples R China
[4] Chinese Acad Med Sci, Beijing 100730, Peoples R China
[5] Jilin Univ, Coll Anim Husb & Vet Med, Changchun 130023, Peoples R China
关键词
Intercellular adhesion molecule-1; Single-chain variable antibody fragment; Expression; Purification; Renaturation; Biological activity; CELL-ADHESION; MONOCLONAL-ANTIBODY; INCLUSION-BODIES; P-SELECTIN; PROTEIN; MOLECULES; VCAM-1; FV;
D O I
10.1590/1414-431X20143276
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Intercellular adhesion molecule-1 (ICAM-1) is an important factor in the progression of inflammatory responses in vivo. To develop a new anti-inflammatory drug to block the biological activity of ICAM-1, we produced a monoclonal antibody (Ka = 4.19x10(-8) M) against human ICAM-1. The anti-ICAM-1 single-chain variable antibody fragment (scFv) was expressed at a high level as inclusion bodies in Escherichia coli. We refolded the scFv (Ka = 2.35x10(-7) M) by ion-exchange chromatography, dialysis, and dilution. The results showed that column chromatography refolding by high-performance Q Sepharose had remarkable advantages over conventional dilution and dialysis methods. Furthermore, the anti-ICAM-1 scFv yield of about 60 mg/L was higher with this method. The purity of the final product was greater than 90%, as shown by denaturing gel electrophoresis. Enzyme-linked immunosorbent assay, cell culture, and animal experiments were used to assess the immunological properties and biological activities of the renatured scFv.
引用
收藏
页码:540 / 547
页数:8
相关论文
共 35 条
[1]   Serum levels of E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients: correlations with clinicopathological features, patient survival and tumour surgery [J].
Alexiou, D ;
Karayiannakis, AJ ;
Syrigos, KN ;
Zbar, A ;
Kremmyda, A ;
Bramis, I ;
Tsigris, C .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (18) :2392-2397
[2]   Upregulation of ICAM-1 expression in the conjunctiva of patients with chronic graft-versus-host disease [J].
Aronni, S ;
Cortes, M ;
Sacchetti, M ;
Lambiase, A ;
Micera, A ;
Sgrulletta, R ;
Bonini, S .
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2006, 16 (01) :17-23
[3]   ICAM-1 and LFA-1 play critical roles in LPS-induced neutrophil recruitment into the alveolar space [J].
Basit, Abdul ;
Reutershan, Joerg ;
Morris, Margaret A. ;
Solga, Michael ;
Rose, C. Edward, Jr. ;
Ley, Klaus .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2006, 291 (02) :L200-L207
[4]   Role of alveolar epithelial ICAM-1 in lipopolysaccharide-induced lung inflammation [J].
Beck-Schimmer, B ;
Madjdpour, C ;
Kneller, S ;
Ziegler, U ;
Pasch, T ;
Wüthrich, RP ;
Ward, PA ;
Schimmer, RC .
EUROPEAN RESPIRATORY JOURNAL, 2002, 19 (06) :1142-1150
[5]   MONOCLONAL-ANTIBODY TO THE ICAM-1 ADHESION SITE REDUCES NEUROLOGICAL DAMAGE IN A RABBIT CEREBRAL EMBOLISM STROKE MODEL [J].
BOWES, MP ;
ZIVIN, JA ;
ROTHLEIN, R .
EXPERIMENTAL NEUROLOGY, 1993, 119 (02) :215-219
[6]   REFOLDING RECOMBINANT PROTEINS - PROCESS STRATEGIES AND NOVEL APPROACHES [J].
CHAUDHURI, JB .
RECOMBINANT DNA TECHNOLOGY II, 1994, 721 :374-385
[7]   Foreword [J].
Chen, Chih-Ming ;
Flandorfer, Hans ;
Chen, Sinn-Wen ;
Lee, Jae-Ho ;
Yen, Yee-Wen ;
Schmetterer, Clemens ;
Ohnuma, Ikuo ;
Wang, Chao-Hong .
JOURNAL OF ELECTRONIC MATERIALS, 2012, 41 (01) :1-1
[8]   Expression, purification, and in vitro refolding of a humanized single-chain Fv antibody against human CTLA4 (CD152) [J].
Chen, LH ;
Huang, QA ;
Wan, L ;
Zeng, LY ;
Li, SF ;
Li, YP ;
Lu, XF ;
Cheng, JQ .
PROTEIN EXPRESSION AND PURIFICATION, 2006, 46 (02) :495-502
[9]  
Clark EDB, 1998, CURR OPIN BIOTECH, V9, P157
[10]   Serum P-selectin, soluble vascular cell adhesion molecule-I (s-VCAM-I) and soluble intercellular adhesion molecule-I (s-ICAM-I) levels in bladder carcinoma patients with different stages [J].
Coskun, U ;
Sancak, B ;
Sen, I ;
Bukan, N ;
Tufan, MA ;
Gülbahar, Ö ;
Sozen, S .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2006, 6 (04) :672-677